Boguslawa Wilk

Senior Director, Analytical Development at Lexicon Pharmaceuticals Inc - The Woodlands, TX, US

Boguslawa Wilk's Colleagues at Lexicon Pharmaceuticals Inc
Peter Holmberg

Executive Director Marketing

Contact Peter Holmberg

Steven Brown

Finance Director, Marketing & Sales

Contact Steven Brown

Rick Finch

Associate Director, Oncology

Contact Rick Finch

Qi Yang

Director, R&D Programs

Contact Qi Yang

Mark 'O''Neill'

Associate Director, Clinical Operations

Contact Mark 'O''Neill'

Godfried Owusu-Ababio

Executive Director, Commercial Supply

Contact Godfried Owusu-Ababio

Charles Schultz

Executive Director Corporate Communications and Patient Advocacy

Contact Charles Schultz

View All Boguslawa Wilk's Colleagues
Boguslawa Wilk's Contact Details
HQ
281-863-3000
Location
Company
Lexicon Pharmaceuticals Inc
Boguslawa Wilk's Company Details
Lexicon Pharmaceuticals Inc logo, Lexicon Pharmaceuticals Inc contact details

Lexicon Pharmaceuticals Inc

The Woodlands, TX, US • 250 - 499 Employees
Major Drugs

Corporate OverviewLexicon Pharmaceuticals is a biopharmaceutical company that has harnessed the power of genetics for drug discovery. Our research team has generated a pipeline of novel drug candidates in clinical development across a broad range of indications.The Genome: Our Source of DiscoveryWe have applied gene knockout technology to thousands of potential drug targets encoded in the human genome. Our scientists have gained a thorough understanding of target biology and identified new points of intervention for future therapies. We have integrated a series of recombinant DNA and chemistry technologies into a systematic drug discovery and development process. Our unique knowledge of targets from the human genome has allowed us to better evaluate and advance novel drug candidates with great promise for patients.A Diverse Pipeline of Targeted TherapiesOur genomics-based approach to drug discovery has enabled our scientists to select drug targets across a broad range of indications with high unmet medical need. All of our drug candidates are new molecular entities discovered internally by our dedicated drug discovery teams and designed to affect particular points on a genetically-defined pathway that can be used to fight a disease process. We have advanced new therapies across a wide spectrum of human disease, from conditions affecting millions of people, such as diabetes, to carcinoid syndrome, an orphan cancer indication with few treatment options.

biopharma knockout novel drug innovation disease pharmaceutical B2B Major Drugs Pharmaceutical Preparations Pharmaceuticals
Details about Lexicon Pharmaceuticals Inc
Frequently Asked Questions about Boguslawa Wilk
Boguslawa Wilk currently works for Lexicon Pharmaceuticals, Inc..
Boguslawa Wilk's role at Lexicon Pharmaceuticals, Inc. is Senior Director, Analytical Development.
Boguslawa Wilk's email address is ***@lexpharma.com. To view Boguslawa Wilk's full email address, please signup to ConnectPlex.
Boguslawa Wilk works in the Pharmaceuticals industry.
Boguslawa Wilk's colleagues at Lexicon Pharmaceuticals Inc are Peter Holmberg, Steven Brown, Rick Finch, Qi Yang, Mark 'O''Neill', Godfried Owusu-Ababio, Charles Schultz and others.
Boguslawa Wilk's phone number is 281-863-3000
See more information about Boguslawa Wilk